“It’s confusing. It’s confusing for even people like me who do this day in and day out,” Alison Bateman-House, a bioethicist at New York University who opposed the federal right-to-try law on the grounds that it would give patients false hope and could potentially lead to patient harm

Quick Read

Are the eligibility criteria used for hip and knee replacements color, income or sex blind? Perhaps not, says new work from Johns Hopkins. Study co-author, our Casey Humbyrd, MD, and her team found that those who met cutoff factors for surgery tended to have higher incomes, more education and be white

Quick Read

How the Americans With Disabilities Act could change the way the nation’s jails and prisons treat addiction. Most jails and prisons around the country forbid methadone and a newer addiction medication, buprenorphine, even when legitimately prescribed, on the grounds that they pose safety and security concerns

Quick Read

Success against sickle-cell would be “the first genetic cure of a common genetic disease” and could free tens of thousands of Americans from agonizing pain

Quick Read

In some places, like rural sub-Saharan Africa, and rural South Asia, people don’t get enough animal products to get their growth cognitive needs,” said Jessica Fanzo, an associate professor at the Johns Hopkins Berman Institute of Bioethics

Quick Read

Despite the mounting death toll of America’s opioid crisis, most facilities that treat substance use disorders don’t offer patients buprenorphine, naltrexone, or methadone—the three medications approved by the FDA for the long-term management of opioid use disorder, according to a new study

Quick Read

Scrolling through the GoFundMe website reveals seemingly an endless number of people who need help or community support. A common theme: the cost of health care

Quick Read

A filing in a Massachusetts lawsuit contains dozens of internal Purdue Pharma documents suggesting the family was far more involved than the company has long contended

Quick Read